可注射纤维软骨形成核心增强大鼠肩袖模型骨腱愈合
研究将成纤维细胞生长因子18通过胶原结合域锚定于脱细胞纤维软骨基质微粒,制备可注射纤维软骨形成核心,并在80只大鼠肩袖损伤修复模型中评估其促进骨腱愈合的效果。结果显示该核心在体外促进软骨形成,在体内促进新骨形成、改善骨腱止点连续性并提高8周失败载荷和刚度。
要点
- 可注射纤维软骨形成核心在体外适合细胞生长并优于刺激软骨形成。
- 在大鼠肩袖修复模型中,该核心组较其他三组新骨形成更多、骨重塑更好。
- 术后8周该核心组肩袖标本失败载荷和刚度最高。
核心结论
- 可注射纤维软骨形成核心提供了一种促进肩袖愈合的新生物学干预手段。
- 作者认为该核心可能成为肩袖撕裂手术修复的新辅助治疗。
研究设计与样本
- 控制性实验室研究,共80只Sprague-Dawley大鼠肩袖损伤模型随机分为4组补充治疗:生理盐水注射(对照组)、AFM-MPs注射、天然FGF18@AFM-MPs注射和CBD-FGF18@AFM-MPs注射。
- 从猪肩袖止点获取正常纤维软骨组织,脱细胞并微粉化制备AFM-MPs;将胶原结合域融合至FGF18 N端合成重组CBD-FGF18,锚定于AFM-MPs胶原纤维制备可注射核心。
- 体外检测CBD-FGF18@AFM-MPs对骨髓间充质干细胞活力和软骨分化的影响;术后4周和8周取肩袖标本行micro-CT、组织学染色和力学测试。
主要发现
- 体外CBD-FGF18@AFM-MPs高度仿生,适合细胞生长和增殖,并优于刺激软骨形成。
- 体内micro-CT显示CBD-FGF18@AFM-MPs组较其他3组新骨形成显著更多、骨重塑更好。
- 组织学上术后4周和8周CBD-FGF18@AFM-MPs组骨腱止点连续性最佳,胶原排列规则,纤维软骨再生广泛。
- 术后8周CBD-FGF18@AFM-MPs组肩袖标本失败载荷和刚度最高。
临床怎么用
- 作者认为可注射纤维软骨形成核心可能成为肩袖撕裂手术修复的新辅助治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: After surgical repair of rotator cuff (RC) tears, the torn tendon heals unsatisfactorily to the greater tuberosity owing to limited regeneration of the bone-tendon (BT) insertion. This situation motivates the need for new interventions to enhance BT healing in the RC repair site. PURPOSE: To develop injectable fibrocartilage-forming cores by tethering fibroblast growth factor 18 (FGF18) on acellular fibrocartilage matrix microparticles (AFM-MPs) and evaluate their efficacy on BT healing. STUDY DESIGN: Controlled laboratory study. METHODS: We harvested normal fibrocartilage tissue from the porcine RC insertion, after which it was decellularized and then micronized for fabricating AFM-MPs. The collagen-binding domain was fused into the N-terminus of FGF18 to synthesize recombinant FGF18 (CBD-FGF18), which was tethered to the collagen fibers of AFM-MPs to prepare the injectable fibrocartilage-forming cores (CBD-FGF18@AFM-MPs). After examining the influence of the CBD-FGF18@AFM-MPs on the viability and chondrogenic differentiation of bone marrow mesenchymal stem cells in vitro, we determined the function of the CBD-FGF18@AFM-MPs on BT healing in a rat RC tear model. A total of 80 Sprague-Dawley rats with RC injuries were randomly assigned to 4 supplemental treatments during RC repair: saline injection (control group), AFM-MPs injection, natural FGF18@AFM-MPs injection, and CBD-FGF18@AFM-MPs injection. At 4 and 8 weeks postoperatively, the harvested RC specimens were evaluated via micro-computed tomography, histologic staining, and mechanical testing. RESULTS: In vitro, the CBD-FGF18@AFM-MPs were highly biomimetic, suitable for cell growth and proliferation, and superior in stimulating chondrogenesis. In vivo micro-computed tomography results showed that the CBD-FGF18@AFM-MPs group had significantly more new bone formation and better bone remodeling than the other 3 groups. Histologically, at 4 and 8 weeks postoperatively, the CBD-FGF18@AFM-MPs group had the best continuity of the BT insertion with regular collagen alignment and extensive fibrocartilage regeneration. Importantly, at 8 weeks postoperatively, the RC specimens from the CBD-FGF18@AFM-MPs group presented the highest failure load and stiffness. CONCLUSION: The injectable fibrocartilage-forming cores provide a new biological intervention to promote RC healing. CLINICAL RELEVANCE: The injectable fibrocartilage-forming cores may be a new complementary treatment for surgical repair of RC tears.
引用
- Yuan Y, Mao Y, Sun B, et al. Injectable Fibrocartilage-Forming Cores Enhance Bone-Tendon Healing in a Rat Rotator Cuff Model. Am J Sports Med. 2025. PMID: 39741471. doi:10.1177/03635465241300138
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。